DK1309315T3 - Hurtigt disintegrerende oral valdecoxib-formulering - Google Patents

Hurtigt disintegrerende oral valdecoxib-formulering

Info

Publication number
DK1309315T3
DK1309315T3 DK01964122T DK01964122T DK1309315T3 DK 1309315 T3 DK1309315 T3 DK 1309315T3 DK 01964122 T DK01964122 T DK 01964122T DK 01964122 T DK01964122 T DK 01964122T DK 1309315 T3 DK1309315 T3 DK 1309315T3
Authority
DK
Denmark
Prior art keywords
molded article
rapidly disintegrating
oral cavity
disintegrating oral
cyclooxygenase
Prior art date
Application number
DK01964122T
Other languages
English (en)
Inventor
Tugrul T Kararli
Trang T Le
Mark J Kontny
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of DK1309315T3 publication Critical patent/DK1309315T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
DK01964122T 2000-08-18 2001-08-17 Hurtigt disintegrerende oral valdecoxib-formulering DK1309315T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22648700P 2000-08-18 2000-08-18

Publications (1)

Publication Number Publication Date
DK1309315T3 true DK1309315T3 (da) 2006-10-09

Family

ID=22849097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01964122T DK1309315T3 (da) 2000-08-18 2001-08-17 Hurtigt disintegrerende oral valdecoxib-formulering

Country Status (14)

Country Link
US (1) US20020071857A1 (da)
EP (1) EP1309315B1 (da)
JP (1) JP2004506680A (da)
AT (1) ATE329583T1 (da)
AU (1) AU2001285011A1 (da)
CA (1) CA2419592A1 (da)
CY (1) CY1105319T1 (da)
DE (1) DE60120710T2 (da)
DK (1) DK1309315T3 (da)
ES (1) ES2265439T3 (da)
MX (1) MXPA03001407A (da)
NZ (1) NZ524124A (da)
PT (1) PT1309315E (da)
WO (1) WO2002015884A2 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL369298A1 (en) * 2001-09-26 2005-04-18 Pharmacia Corporation Intraorally disintegrating valdecoxib compositions
CA2462881A1 (en) * 2001-10-10 2003-04-17 Pharmacia Corporation Intraorally disintegrating valdecoxib compositions prepared by spray drying process
WO2003049720A1 (en) * 2001-12-07 2003-06-19 Merck & Co., Inc. Combination therapy comprising a cyclooygenase-2 inhibitor
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
WO2004026235A2 (en) * 2002-09-20 2004-04-01 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
BRPI0302736B8 (pt) * 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
AU2005320672B2 (en) * 2004-12-27 2011-01-06 Astellas Pharma Inc. Stable particulate pharmaceutical composition of solifenacin or salt thereof
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR101335932B1 (ko) * 2005-03-07 2013-12-04 바이엘 헬스케어 엘엘씨 암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
CA2614468A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8252329B2 (en) * 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
CA2704929C (en) * 2007-08-07 2018-05-15 Pamela Palmer Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
US20100233272A1 (en) * 2007-11-15 2010-09-16 Leah Elizabeth Appel Dosage forms comprising celecoxib providing both rapid and sustained pain relief
AU2008357475B2 (en) 2008-06-04 2012-11-01 Colgate-Palmolive Company Oral care implement with cavitation system
US20100075930A1 (en) * 2008-09-03 2010-03-25 Yoel Ovil Salicylic salt compositions and related method of treatment of cardiac conditions
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9259420B2 (en) * 2012-09-13 2016-02-16 Cba Pharma, Inc. Tetrandrine pharmaceutical formulations
US11058856B2 (en) 2014-12-23 2021-07-13 Acelrx Pharmaceuticals, Inc. Systems, devices and methods for dispensing oral transmucosal dosage forms
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CA3088728A1 (en) * 2018-01-21 2019-07-25 Bernie D. KASTNER Migraine treatment preparation and method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
ATE172637T1 (de) * 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
EP0553777B1 (en) * 1992-01-29 2002-04-24 Takeda Chemical Industries, Ltd. Fast dissolving tablet and its production
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
SK284330B6 (sk) * 1996-05-17 2005-01-03 Merck & Co., Inc. Použitie 3-fenyl-4-(4-metylsulfonyl)fenyl)-2-(5H)-furanónu
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
JP2002529406A (ja) * 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド ＧＡＢＡＡα５逆活性薬と、ＣＯＸ−２阻害剤、ＮＳＡＩＤ、エストロゲン、又はビタミンＥとの組合わせ
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
WO2001039749A2 (en) * 1999-11-30 2001-06-07 Panacea Biotec Limited Fast dissolving composition with prolonged sweet taste

Also Published As

Publication number Publication date
ATE329583T1 (de) 2006-07-15
NZ524124A (en) 2004-09-24
ES2265439T3 (es) 2007-02-16
CA2419592A1 (en) 2002-02-28
EP1309315B1 (en) 2006-06-14
MXPA03001407A (es) 2003-06-06
US20020071857A1 (en) 2002-06-13
WO2002015884A3 (en) 2002-07-25
AU2001285011A1 (en) 2002-03-04
WO2002015884A2 (en) 2002-02-28
DE60120710T2 (de) 2007-06-14
CY1105319T1 (el) 2010-03-03
DE60120710D1 (de) 2006-07-27
PT1309315E (pt) 2006-09-29
EP1309315A2 (en) 2003-05-14
JP2004506680A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
PT1309315E (pt) Formulacao oral de desintegracao rapida de valdecoxib
EP1120109A3 (en) Rapidly disintegrating and fast dissolving solid dosage form
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
NO20070887L (no) Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet
MY128368A (en) Method for producing quickly decomposable solid pharmaceutical preparations
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
CA2990445A1 (en) Thermo-kinetic mixing for pharmaceutical applications
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
BR0015994A (pt) Composição de dissolução rápida com sabor doce prolongado
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
IL158216A0 (en) Disposable vaginal cannula for the simultaneous administration of drugs in different forms
WO2010019279A8 (en) Pharmaceutical compositions configured to deter dosage form splitting
DE60123447D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe
DE69830176D1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
AR020998A1 (es) Formulaciones de liberacion controlada de metamizol
PL1499278T3 (pl) Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
CN105581991A (zh) 一种酒石酸唑吡坦舌下片及其制备方法
ECSP993186A (es) Formulaciones de liberacion controlada de metamizol
CN109528698A (zh) 花姜酮或其前药用于制备镇静药物的用途
EP4008314A3 (en) Thermo-kinetic mixing for pharmaceutical applications
CY1118235T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ii
Iakovenko et al. The urgency of developing dental medications in the form of medicated chewing gums